About
Julian Englert is the co-founder and CEO of Adaptyv Bio, a Lausanne-based techbio company building automated wet-lab infrastructure for protein engineering and AI-driven biology. Public sources tie him closely to Adaptyv's protein-design platform, Y Combinator background, and biotech conference speaking activity. Available evidence positions him as an operating founder in the protein engineering ecosystem, not as an investor or fund manager.
Areas of interest
biotechprotein engineeringsynthetic biologylab automationmachine learningAI for biologydrug discovery infrastructure